Skip to main content
. Author manuscript; available in PMC: 2018 May 28.
Published in final edited form as: J Med Chem. 2017 Apr 24;60(9):3727–3738. doi: 10.1021/acs.jmedchem.6b01758

Figure 1.

Figure 1

Activity of the compounds in the influenza virus plaque reduction assay. MDCK cells were infected with influenza virus (strain A/HK/7/87; 30 PFU per well) in the presence of the test compounds. After 72 h incubation, plaques were visualized by crystal violet staining. VC: mock-treated virus control; CC: uninfected cell control.